标题
Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies
作者
关键词
-
出版物
Frontiers in Immunology
Volume 8, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2017-03-13
DOI
10.3389/fimmu.2017.00277
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization
- (2017) Silvia Pesce et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Human lung natural killer cells are predominantly comprised of highly differentiated hypofunctional CD69 − CD56 dim cells
- (2017) Nicole Marquardt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- NSCLC, early stageNeoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
- (2016) P.M. Forde et al. ANNALS OF ONCOLOGY
- MHC class I chain-related molecule A and B expression is upregulated by cisplatin and associated with good prognosis in patients with non-small cell lung cancer
- (2016) Riki Okita et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer
- (2016) Raghvendra M. Srivastava et al. CLINICAL CANCER RESEARCH
- Tertiary lymphoid structures, drivers of the anti-tumor responses in human cancers
- (2016) Marie-Caroline Dieu-Nosjean et al. IMMUNOLOGICAL REVIEWS
- Clinical potential of necitumumab in non-small cell lung carcinoma
- (2016) Fred Hirsch et al. OncoTargets and Therapy
- Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
- (2016) S. J. Blake et al. Cancer Discovery
- EGFR-targeted therapy results in dramatic early lung tumor regression accompanied by imaging response and immune infiltration in EGFR mutant transgenic mouse models
- (2016) Abhilash Venugopalan et al. Oncotarget
- Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches
- (2016) Sebastian Carotta Frontiers in Immunology
- Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
- (2015) Yasuhiko Ohshio et al. CANCER SCIENCE
- Identification of a Human Natural Killer Cell Lineage-Restricted Progenitor in Fetal and Adult Tissues
- (2015) Virginie M. Renoux et al. IMMUNITY
- Role of NK cells in immunotherapy and virotherapy of solid tumors
- (2015) Claudia Cantoni et al. Immunotherapy
- CD160 is essential for NK-mediated IFN-γ production
- (2015) Tony C. Tu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD56brightCD16−NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+T Cell Proliferation
- (2015) Fabio Morandi et al. JOURNAL OF IMMUNOLOGY
- NK Cells of Kidney Transplant Recipients Display an Activated Phenotype that Is Influenced by Immunosuppression and Pathological Staging
- (2015) Ulrike Hoffmann et al. PLoS One
- Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
- (2015) Riki Okita et al. PLoS One
- NCR+ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures
- (2015) Paolo Carrega et al. Nature Communications
- Identification of an ADAM17 Cleavage Region in Human CD16 (FcγRIII) and the Engineering of a Non-Cleavable Version of the Receptor in NK Cells
- (2015) Yawu Jing et al. PLoS One
- The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
- (2015) Antonino Bruno et al. NEOPLASIA
- CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
- (2014) P. Carrega et al. JOURNAL OF IMMUNOLOGY
- NK Cell Phenotypic Modulation in Lung Cancer Environment
- (2014) Shi Jin et al. PLoS One
- TGF- -inducible microRNA-183 silences tumor-associated natural killer cells
- (2014) S. S. Donatelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation
- (2012) Paola Vacca et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cytotoxicity of CD56bright NK Cells towards Autologous Activated CD4+ T Cells Is Mediated through NKG2D, LFA-1 and TRAIL and Dampened via CD94/NKG2A
- (2012) Natasja Nielsen et al. PLoS One
- Mapping of NKp46+ Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues
- (2012) Elena Tomasello et al. Frontiers in Immunology
- Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
- (2011) S. Platonova et al. CANCER RESEARCH
- Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
- (2011) Emilie Mamessier et al. JOURNAL OF CLINICAL INVESTIGATION
- Updated Technology to Produce Highly Immunogenic Dendritic Cell-derived Exosomes of Clinical Grade
- (2010) Sophie Viaud et al. JOURNAL OF IMMUNOTHERAPY
- CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets
- (2009) J. Yu et al. BLOOD
- Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells
- (2009) Christine Sers et al. INTERNATIONAL JOURNAL OF CANCER
- Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56brightCD16− cells and display an impaired capability to kill tumor cells
- (2008) Paolo Carrega et al. CANCER
- Natural Killer Cell Accumulation in Tumors Is Dependent on IFN- and CXCR3 Ligands
- (2008) M. Wendel et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started